Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-05

FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s original application for fluphenazine hydrochloride, a generic antipsychotic. The approval confirms the generic version is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine hydrochloride (Fluphenazine hydrochloride)

Snippet

ORIG AP for FLUPHENAZINE HYDROCHLORIDE (FLUPHENAZINE HYDROCHLORIDE)